Michael Gleimer

Continuous T cell receptor signaling required for synapse maintenance and full effector potential

Johannes B. Huppa, Michael Gleimer, Cenk Sumen et al. · Nature Immunology · 2003 · 401 citations

Life Sciences, Cell Biology, Immunology +15

Synergistic Polymorphism at Two Positions Distal to the Ligand-Binding Site Makes KIR2DL2 a Stronger Receptor for HLA-C Than KIR2DL3

Achim K. Moesta, Paul J. Norman, Makoto Yawata et al. · The Journal of Immunology · 2008 · 383 citations · Full text

Life Sciences, Genetics, Immunology +17

KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C

Thorsten Graef, Achim K. Moesta, Paul J. Norman et al. · The Journal of Experimental Medicine · 2009 · 235 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans

Paul J. Norman, Laurent Abi-Rached, Ketevan Gendzekhadze et al. · Nature Genetics · 2007 · 221 citations

Life Sciences, Genetics, Immunology +11

The Protein Made from a Common Allele of <i>KIR3DL1</i> ( <i>3DL1*004</i> ) Is Poorly Expressed at Cell Surfaces due to Substitution at Positions 86 in Ig Domain 0 and 182 in Ig Domain 1

Marcelo J. Pando, Clair M. Gardiner, Michael Gleimer et al. · The Journal of Immunology · 2003 · 212 citations · Full text

Life Sciences, Genetics, Immunology +17